Effects of 2-year vitamin B12 and folic acid supplementation in hyperhomocysteinemic elderly on arterial stiffness and cardiovascular outcomes within the B-PROOF trial

Journal of Hypertension

Volumn 33, Issue 9, 2015, Pages 1897-1906

  Van Dijk, Suzanne C ^a   Enneman, Anke W ^a   Swart, Karin M A ^b   Van Wijngaarden, Janneke P ^c   Ham, Annelies C ^a   Brouwer Brolsma, Elske M ^c   Van Der Zwaluw, Nikita L ^c   Blom, Henk J ^b   Feskens, Edith J ^c   Geleijnse, Johanna Marianna ^c   Van Schoor, Natasja M ^b   Dhonukshe Rutten, Rosalie A M ^c   De Jongh, Renate T ^b   Lips, Paul ^b   De Groot, Lisette C P G M ^c   Uitterlinden, Andre G ^a,d   Smulders, Yvo M ^b,e   Van Den Meiracker, Anton H ^a   Mattace Raso, Francesco U S ^a   Van Der Velde, Nathalie ^a,f  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c WAGENINGEN UNIVERSITY   (Netherlands)

^d Netherlands Consortium for Healthy Ageing   (Netherlands)

^e VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^f ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Arterial stiffness; Cardiovascular disease; Cerebrovascular disorders; Homocysteine; Nutrition; Trials

Indexed keywords

CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE;

AGED; ARTERIAL STIFFNESS; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR PARAMETERS; CEREBROVASCULAR DISEASE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; FOLLOW UP; HUMAN; HYPERHOMOCYSTEINEMIA; INTERVENTION STUDY; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PULSE WAVE; RANDOMIZED CONTROLLED TRIAL; STRUCTURED QUESTIONNAIRE; VITAMIN SUPPLEMENTATION; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; DIETARY SUPPLEMENT; DRUG EFFECTS; MORTALITY; PATHOPHYSIOLOGY; PHYSIOLOGY; RISK FACTOR; TREATMENT OUTCOME; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ATHEROSCLEROSIS; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; CAROTID INTIMA-MEDIA THICKNESS; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FEMALE; FOLIC ACID; HUMANS; HYPERHOMOCYSTEINEMIA; MALE; PULSE WAVE ANALYSIS; RISK FACTORS; TREATMENT OUTCOME; VASCULAR STIFFNESS; VITAMIN B 12;

EID: 84942597858     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0000000000000647     Document Type: Article

References (31)

1. de Ruijter W, Westendorp RG, Assendelft WJ, den Elzen WP, de Craen AJ, leCessie S, Gussekloo J. Use of Framingham risk score and new biomarkers to predict cardiovascular mortality in older people: population based observational cohort study. BMJ 2009; 338:a3083.
2. Clarke R, Halsey J, Lewington S, Lonn E, Armitage J, Manson JE, et al., B-Vitamin Treatment Trialists' Collaboration. Effects of lowering homocysteine levels with B vitamins on cardiovascular disease, cancer, and cause-specific mortality: meta-analysis of 8 randomized trials involving 37 485 individuals. Arch Intern Med 2010; 170:1622-1631.
3. Huang T, Chen Y, Yang B, Yang J, Wahlqvist ML, Li D. Meta-analysis of B vitamin supplementation on plasma homocysteine, cardiovascular and all-cause mortality. Clin Nutr 2012; 31:448-454.
4. Ji Y, Tan S, Xu Y, Chandra A, Shi C, Song B, et al. Vitamin B supplementation, homocysteine levels, and the risk of cerebrovascular disease: a meta-analysis. Neurology 2013; 81:1298-1307.
5. van Dijk RA, Rauwerda JA, Steyn M, Twisk JW, Stehouwer CD. Longterm homocysteine-lowering treatment with folic acid plus pyridoxine is associated with decreased blood pressure but not with improved brachial artery endothelium-dependent vasodilation or carotid artery stiffness: a 2-year, randomized, placebo-controlled trial. Arterioscler Thromb Vasc Biol 2001; 21:2072-2079.
6. Mangoni AA, Sherwood RA, Asonganyi B, Swift CG, Thomas S, Jackson SH. Short-term oral folic acid supplementation enhances endothelial function in patients with type 2 diabetes. Am J Hypertens 2005; 18:220-226.
7. Mangoni AA, Sherwood RA, Swift CG, Jackson SH. Folic acid enhances endothelial function and reduces blood pressure in smokers: a randomized controlled trial. J Intern Med 2002; 252:497-503.
8. Khandanpour N, Armon MP, Jennings B, Finglas PM, Willis G, Clark A, Meyer FJ. Randomized clinical trial of folate supplementation in patients with peripheral arterial disease. Br J Surg 2009; 96:990-998.
9. Durga J, Bots ML, Schouten EG, Grobbee DE, Kok FJ, Verhoef P. Effect of 3 y of folic acid supplementation on the progression of carotid intima-media thickness and carotid arterial stiffness in older adults. Am J Clin Nutr 2011; 93:941-949.
10. Mashavi M, Hanah R, Boaz M, Gavish D, Matas Z, Fux A, Shargorodsky M. Effect of homocysteine-lowering therapy on arterial elasticity and metabolic parameters in metformin-treated diabetic patients. Atherosclerosis 2008; 199:362-367.
11. Potter K, Hankey GJ, Green DJ, Eikelboom J, Jamrozik K, Arnolda LF. The effect of long-term homocysteine-lowering on carotid intimamedia thickness and flow-mediated vasodilation in stroke patients: a randomized controlled trial and meta-analysis. BMC Cardiovasc Disord 2008; 8.
12. Title LM, Ur E, Giddens K, McQueen MJ, Nassar BA. Folic acid improves endothelial dysfunction in type 2 diabetes: an effect independent of homocysteine-lowering. Vasc Med 2006; 11:101-109.
13. Tochihara Y, Whiting MJ, Barbara JA, Mangoni AA. Effects of pre vs. intra-dialysis folic acid on arterial wave reflections and endothelial function in patients with end-stage renal disease. Br J Clin Pharmacol 2008; 66:717-722.
14. Williams C, Kingwell BA, Burke K, McPherson J, Dart AM. Folic acid supplementation for 3 wk reduces pulse pressure and large artery stiffness independent of MTHFR genotype.Am J Clin Nutr 2005; 82:26-31.
15. Zoungas S, McGrath BP, Branley P, Kerr PG, Muske C, Wolfe R, et al. Cardiovascular morbidity and mortality in the Atherosclerosis and Folic Acid Supplementation Trial (ASFAST) in chronic renal failure: a multicenter, randomized, controlled trial. J Am Coll Cardiol 2006; 47:1108-1116.
16. Van Bortel LM, Laurent S, Boutouyrie P, Chowienczyk P, Cruickshank JK, De Backer T, et al., Artery Society, European Society of Hypertension Working Group on Vascular Structure and Function, European Network for Noninvasive Investigation of Large Arteries. Expert consensus document on the measurement of aortic stiffness in daily practice using carotid-femoral pulse wave velocity. J Hypertens 2012; 30:445-448.
17. van Dijk SC, Smulders YM, Enneman AW, Swart KM, van Wijngaarden JP, Ham AC, et al. Homocysteine level is associated with aortic stiffness in elderly: cross-sectional results from the B-PROOF study. J Hypertens 2013; 31:952-959.
18. van Wijngaarden JP, Dhonukshe-Rutten RA, van Schoor NM, van der Velde N, Swart KM, Enneman AW, et al. Rationale and design of the BPROOF study, a randomized controlled trial on the effect of supplemental intake of vitamin B12 and folic acid on fracture incidence. BMC Geriatr 2011; 11.
19. Lips P. Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. Endocr Rev 2001; 22:477-501.
20. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130:461-470.
21. Whitworth JA, World Health Organization, International Society of Hypertension Writing Group. 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens 2003; 21:1983-1992.
22. Homocysteine Lowering Trialists' Collaboration. Dose-dependent effects of folic acid on blood concentrations of homocysteine: a metaanalysis of the randomized trials. Am J Clin Nutr 2005; 82:806-812.
23. Roberts WC, Kragel AH, Gertz SD, Roberts CS. Coronary arteries in unstable angina pectoris, acute myocardial infarction, and sudden coronary death. Am Heart J 1994; 127:1588-1593.
24. Pignoli P, Tremoli E, Poli A, Oreste P, Paoletti R. Intimal plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging. Circulation 1986; 74:1399-1406.
25. Nichols WW. Clinical measurement of arterial stiffness obtained from noninvasive pressure waveforms. Am J Hypertens 2005; 18: 3S-10S.
26. O'Rourke MF, Hashimoto J. Mechanical factors in arterial aging: a clinical perspective. J Am Coll Cardiol 2007; 50:1-13.
27. Smulders YM, Blom HJ. The homocysteine controversy. J Inherit Metab Dis 2011; 34:93-99.
28. de Bree A, van der Put NM, Mennen LI, Verschuren WM, Blom HJ, Galan P, et al. Prevalences of hyperhomocysteinemia, unfavorable cholesterol profile and hypertension in European populations. Eur J Clin Nutr 2005; 59:480-488.
29. Wallbach M, Lehnig LY, Schroer C, Helms HJ, Luders S, Patschan D, et al. Effects of baroreflex activation therapy on arterial stiffness and central hemodynamics in patient with resistant hypertension. J Hypertens 2015; 33:181-186.
30. Georgianos PI, Agarwal R. Effect of lisinopril and atenolol on aortic stiffness in patients on hemodialysis. Clin J Am Soc Nephrol 2015; 10:639-645.
31. van Wijngaarden JP, Swart KM, Enneman AW, Dhonukshe-Rutten RAM, van Dijk SC, Ham AC, et al. Effect of daily vitamin B12 and folic acid supplementation on fracture incidence in elderly with an elevated plasma homocysteine level: B-PROOF, a randomized controlled trial. Am J Clin Nutr 2014; 100:1578-1586.